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Increased GABAB receptor signaling 
in a rat model for schizophrenia
Martijn M. Selten1,*, Francisca Meyer2,*, Wei Ba1,3, Astrid Vallès2,4, Dorien A. Maas1,2, 
Moritz Negwer5, Vivian D. Eijsink2, Ruben W. M. van Vugt2, Josephus A. van Hulten2, 
Nick H. M. van Bakel2, Joey Roosen2, Robert J. van der Linden2, Dirk Schubert1, 
Michel M. M. Verheij1, Nael Nadif Kasri1,3,† & Gerard J. M. Martens2,†
Schizophrenia is a complex disorder that affects cognitive function and has been linked, both in 
patients and animal models, to dysfunction of the GABAergic system. However, the pathophysiological 
consequences of this dysfunction are not well understood. Here, we examined the GABAergic system in 
an animal model displaying schizophrenia-relevant features, the apomorphine-susceptible (APO-SUS) 
rat and its phenotypic counterpart, the apomorphine-unsusceptible (APO-UNSUS) rat at postnatal day 
20–22. We found changes in the expression of the GABA-synthesizing enzyme GAD67 specifically in the 
prelimbic- but not the infralimbic region of the medial prefrontal cortex (mPFC), indicative of reduced 
inhibitory function in this region in APO-SUS rats. While we did not observe changes in basal synaptic 
transmission onto LII/III pyramidal cells in the mPFC of APO-SUS compared to APO-UNSUS rats, we 
report reduced paired-pulse ratios at longer inter-stimulus intervals. The GABAB receptor antagonist 
CGP 55845 abolished this reduction, indicating that the decreased paired-pulse ratio was caused by 
increased GABAB signaling. Consistently, we find an increased expression of the GABAB1 receptor 
subunit in APO-SUS rats. Our data provide physiological evidence for increased presynaptic GABAB 
signaling in the mPFC of APO-SUS rats, further supporting an important role for the GABAergic system 
in the pathophysiology of schizophrenia.
Schizophrenia is a complex mental disorder thought to result from a combination of genetic and environmental 
factors that provide vulnerability to early- and later-life stressors1–3. Growing evidence suggests that schizophre-
nia may arise from abnormal connectivity between various integrative brain regions, especially the prefrontal 
cortex (PFC), the medial temporal lobe, and striatal regions4–7. For several decades, schizophrenia research was 
guided by the dopamine hypothesis8. However, this hypothesis has expanded more recently into a view including 
other neurotransmitters such as serotonin9, glutamate10 and γ -aminobutyric acid (GABA)11.
Dysfunction of the GABAergic system in schizophrenia has been well documented by postmortem studies 
showing alterations in a number of pre- and post-synaptic markers of inhibitory neurotransmission thought to be 
most prominent in parvalbumin positive (PV+) neurons12. For example, reduced densities of calbindin-positive 
(CB+) and PV+ GABAergic interneurons have been observed in the PFC of schizophrenia patients13–15. In addi-
tion, protein levels of GABA transporter 1 (GAT1) are reduced in the PFC of schizophrenia patients16. Also, 
PFC levels of the GABA synthesizing enzyme GAD67 are reduced in schizophrenia, which can be attributed to 
reduced expression in PV+ cells specifically17 and is indicative of reduced GABAergic signaling18. At the synap-
tic level, the GABAAα 2 subunit, which is prominently expressed in synapses formed by chandelier cells on the 
axon initial segment of pyramidal neurons, is upregulated in schizophrenia patients19. In line with these results, a 
genetic model of schizophrenia, the Erbb4 knock-out mouse, shows changes in GABAAα 2 and GAT1 density as 
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well as a reduced number of inhibitory synapses on excitatory pyramidal cells12,20. Conversely, excitatory inputs 
onto PV+ cells are decreased in these mice12,20.
To explore the pathophysiological mechanisms underlying schizophrenia, we used the apomorphine-susceptible 
(APO-SUS) rat model and its phenotypic counterpart, the apomorphine-unsusceptible (APO-UNSUS) rat. These 
two rat lines have been pharmacogenetically selected and bred from an outbred Wistar population based on 
their stereotypical gnawing responses to the dopamine D1/D2 agonist apomorphine21. The APO-SUS rat is a 
well-characterized animal model that displays schizophrenia-relevant features during adulthood, such as altered 
density of central dopamine receptors22, high sensitivity to dopaminergic drugs (i.e., apomorphine and amphet-
amine)21,23,24, decreased prepulse inhibition and diminished latent inhibition24,25, increased novelty-induced 
exploration and accumbal dopamine response21,23,26, and an increased HPA-axis response to stress22, as well as 
learning and memory deficits27,28. However, the pathophysiology underlying the phenotypes observed in this 
model remains unknown.
In the present study, we compared the inhibitory system in the medial PFC (mPFC) of APO-SUS and 
APO-UNSUS rats at postnatal day (PND) 20–22. We found a decrease in the protein level of GAD67 as well 
as a reduced cell-count for GAD67+ cells specifically in the prelimbic region (PRL) of the mPFC. While basal 
synaptic transmission onto LII/III pyramidal cells was not different between the two rat lines, we report a 
decrease in the paired-pulse ratio in APO-SUS rats at longer (≥ 150 ms) intervals compared to APO-UNSUS 
rats. Importantly, this decrease could be abolished by application of the GABAB antagonist CGP 55845, 
indicating that the decreased paired-pulse ratio was caused by an increased activity in GABAB signaling. 
We indeed observed an increase in GABAB receptor expression in the mPFC of APO-SUS rats compared to 
APO-UNSUS rats. Collectively, our data identify GABAB receptor signaling as a possible player in the etiology 
of schizophrenia.
Results
Reduced levels of GAD67 in the mPFC of APO-SUS rats. Previous studies have reported altered levels 
of specific interneuron markers in schizophrenia patients13–17,29. In order to determine whether the number of 
GABAergic interneurons is altered in APO-SUS compared to APO-UNSUS rats, we performed western blot anal-
ysis to measure the protein expression levels of GAD67, CB and CR in punches from the mPFC of PND 20–22 
rats (Fig. 1). We found protein levels of GAD67 to be reduced by ~35% in APO-SUS rats (Fig. 1a,d; p = 0.04). 
Conversely, we found no change in the levels of CB (Fig. 1b,d; p = 0.33) and CR (Fig. 1c,d; p = 0.99) between the 
two rat lines.
Reduction of GAD67+ cells in the prelimbic region, but not the infralimbic region, of the mPFC 
of APO-SUS rats. Next, we wanted to assess whether the decrease in GAD67 protein levels in the mPFC was 
due to a decreased amount of GAD67 per cell or to a decrease in the total number of interneurons. To this end we 
performed immunohistochemistry to assess the number of interneurons positive for GAD67. We also assessed 
the number of CB+, CR+ and PV+ cells, which together label ~90% of GABAergic interneurons30. We used cor-
onal sections of the mPFC and analyzed the number of positive cells separately for the prelimbic (PRL)- and 
infralimbic (IL) region, two subregions of the mPFC.
We found a significant decrease of GAD67+ cells specifically in the PRL (APO-UNSUS 6.12 ± 0.25 cells/mm2; 
APO-SUS 5.25 ± 0.15 cells/mm2, p = 0.012; Fig. 2a,b,i), but not the IL (APO-UNSUS 7.25 ± 0.29 cells/mm2; 
APO-SUS 6.60 ± 0.28 cells/mm2, p = 0.13; Fig. 2a,b,j) in APO-SUS rats. We found no changes in the lev-
els of CB+, CR+ and PV+ cells in both the PRL (CB+: APO-UNSUS 9.32 ± 0.79 cells/mm2; APO-SUS 
9.82 ± 0.60 cells/mm2, p = 0.64; CR+: APO-UNSUS 3.06 ± 0.16 cells/mm2; APO-SUS 3.43 ± 0.22 cells/mm2, 
p = 0.19; PV+: APO-UNSUS 2.32 ± 0.11 cells/mm2; APO-SUS 2.49 ± 0.21 cells/mm2, p = 0.47), or IL 
(CB+: APO-UNSUS 10.36 ± 0.70 cells/mm2; APO-SUS 9.33 ± 0.59 cells/mm2, p = 0.33; CR+: APO-UNSUS 
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Figure 1. Reduced expression of GAD67, but not Calbindin (CB) and Calretinin (CR) in the medial 
prefrontal cortex (mPFC) of APO-SUS rats. (a–c) Representative immunoblot images for GAD67 (a), CB  
(b) and CR (c,d) quantification of western blot analysis for CB, CR and GAD67 in APO-UNSUS and APO-
SUS mPFC. Expression is normalized to APO-UNSUS expression of the respective protein. Sample size (n) is 
indicated in the bars. Data is presented as mean ± SEM, * p < 0.05. Student’s t-test.
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4.12 ± 0.32 cells/mm2; APO-SUS 3.85 ± 0.37 cells/mm2, p = 0.58; PV+: APO-UNSUS 0.99 ± 0.08 cells/mm2; 
APO-SUS 1.13 ± 0.11 cells/mm2, p = 0.30; Fig. 2c–j). The fact that we did not observe changes in the CB+ 
CR+ and PV+ populations, which suggests the reduction in GAD67 is due to a reduced level of GAD67 per cell, 
rather than a reduction in the total amount of interneurons, specifically in the PRL.
Unaltered basal synaptic input on LII/III pyramidal neurons in the mPFC. Since reduced levels of 
GAD67 are indicative of reduced interneuronal activity31,32, we subsequently tested if the observed changes in 
GAD67 protein levels would be accompanied by changes at the electrophysiological level. In order to assess basal 
synaptic input we used whole-cell voltage clamp to record miniature inhibitory postsynaptic currents (mIPSCs) 
Figure 2. Reduced number of GAD67+ cells in the PRL, but not the IL. Representative images of a staining 
for GAD67 (a,b), Calbindin (CB) (c,d) Calretinin (CR) (e,f) and parvalbumin (PV) (g,h) and quantification in 
the prelimbic (PRL) (i) and infralimbic (IL) region (j) of the medial prefrontal cortex. GAD67, CB, CR and PV 
staining in green, Hoechst in blue. Sample size (n) is indicated in the bars. Scale bar: 200 μ m. Data is presented 
as mean ± SEM. **p < 0.01. Student’s t-test.
www.nature.com/scientificreports/
4Scientific RepoRts | 6:34240 | DOI: 10.1038/srep34240
from layer (L) II/III pyramidal neurons in the mPFC (Fig. 3a–c). We found no difference in both mIPSC 
amplitude (APO-UNSUS 23.04 ± 0.32 pA; APO-SUS 22.33 ± 0.37 pA, p = 0.16) and frequency (APO-UNSUS 
1.20 ± 0.12 Hz; APO-SUS 1.16 ± 0.14 Hz, p = 0.83). Similarly, no differences were found in miniature excitatory 
postsynaptic currents (mEPSCs) between the two rat lines (amplitude: APO-UNSUS 16.20 ± 0.31 pA; APO-SUS 
15.34 ± 0.31 pA; p = 0.08; frequency: APO-UNSUS 2.99 ± 0.26 Hz; APO-SUS 2.98 ± 0.42 Hz, p = 0.98) (Fig. 3d–f).
Previous studies have shown that changes in postsynaptic GABA receptor subunit composition are reflected 
in the decay time of mIPSC33,34. We found no changes in the mIPSC decay time in APO-SUS rats (APO-UNSUS 
15.58 ± 0.52 ms; APO-SUS 13.46 ± 0.93 ms, p = 0.06), indicating the postsynaptic receptor content of inhibitory 
synapses was unaltered (Fig. 3g).
Next, we measured the maximal response to bath application of 20 μ M GABA (Fig. 3h). No difference was 
observed between APO-UNSUS and APO-SUS rats (APO-UNSUS 154.1 ± 48.3 pA; APO-SUS 163.9 ± 51.2 pA, 
p = 0.78), indicating that the total number of GABAA receptors was identical. Together, these data show that there 
is no difference in basal synaptic inhibitory and excitatory input connectivity onto LII/III pyramidal cells in the 
mPFC between APO-UNSUS and APO-SUS rats.
We then analyzed pyramidal cell morphology of cells that were filled with biocytin during the recordings. All 
cells had a typical pyramidal morphology, hallmarked by a skirt of basal dendrites radiating ~200 μ m from the 
Figure 3. No changes in basal synaptic transmission and morphology in LII/III pyramidal cells in the 
medial prefrontal cortex (mPFC). (a) Representative traces of miniature inhibitory post-synaptic currents 
(mIPSCs) recorded from LII/III pyramidal cells from acute brain slices from APO-UNSUS and APO-SUS rats.  
(b,c) Cumulative distributions of mIPSC amplitudes (b) and inter-event intervals (IEI) (c) from APO-UNSUS and 
APO-SUS rats. (d) Representative traces of miniature excitatory post-synaptic currents (mEPSCs) recorded 
from LII/III pyramidal cells from acute brain slices from APO-UNSUS and APO-SUS rats (e,f) Cumulative 
distributions of mEPSC amplitudes (e) and inter-event intervals (f) from APO-UNSUS and APO-SUS 
rats. (g) Representative traces (scaled) and distribution of mIPSC decay time. (h) Representative traces and 
quantification of systemic GABA (20 μ M) application from APO-UNSUS and APO-SUS rats. Black bar 
indicates GABA application. (i) Representative reconstructions of LII/III pyramidal neurons from mPFC. 
Sample size (n) is indicated in the bars as number of cells/number of animals. Bar graphs are presented as 
mean ± SEM. Student’s t-test.
www.nature.com/scientificreports/
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soma, and a single long apical dendrite that reached into upper LI (Fig. 3i). The apical dendrite mostly branched 
close to the soma, and had an apical tuft close to the pia mater, mainly within LI, consistent with previous 
reports35. The dendritic morphology of both apical and basal dendrites did not differ between pyramidal cells 
from APO-UNSUS and APO-SUS rats (Table 1).
Reduction in paired-pulse ratio through GABAB receptor signaling in the mPFC of APO-SUS rats. 
Next, we investigated the release probability of inhibitory synapses onto LII/III pyramidal cells by recording the 
paired-pulse ratio following stimulation in the same layer in the PFC. We recorded paired-pulse ratios at different 
inter-stimulus intervals (ISI) (Fig. 4a,b) and found that the paired-pulse ratio were indistinguishable between 
both rat lines for short ISIs (≤ 100 ms) (50 ms APO-UNSUS 0.96 ± 0.03; APO-SUS 0.94 ± 0.04, p = 0.67; 100 ms 
APO-UNSUS 0.92 ± 0.03; APO-SUS 0.89 ± 0.04, p = 0.65), whereas LII/III pyramidal cells from APO-SUS rats 
showed a reduced paired-pulse ratio at longer ISIs (≥ 150 ms) (150 ms APO-UNSUS 0.88 ± 0.03; APO-SUS 
0.77 ± 0.02; p < 0.01; 200 ms APO-UNSUS 0.81 ± 0.03; APO-SUS 0.71 ± 0.02; p < 0.01; 500 ms APO-UNSUS 
0.82 ± 0.02; APO-SUS 0.75 ± 0.02; p < 0.05; Fig. 4b). Whereas changes at short ISIs are indicative of an altered 
release probability, changes in paired-pulse ratios for longer ISIs can be indicative of reduced presynaptic calcium 
inflow36. Previous studies have shown that a reduced presynaptic calcium inflow can be caused by increased ret-
rograde signaling via nitric oxide37 and endocannabinoids38, or through binding of GABA to presynaptic GABAB 
receptors, which upon activation negatively influence Ca2+ inflow through voltage gated Ca2+-channels39. Since 
only GABAB receptors act at the sub-second time range, we investigated the involvement of GABAB receptor 
signaling by recording the paired-pulse ratio in the presence of the GABAB receptor antagonist CGP 55845. In 
APO-SUS rats, the paired-pulse ratio at 50 ms and 100 ms was unaffected by CGP 55845, consistent with GABAB 
receptor activation time40. Interestingly, we found that the reduced paired-pulse ratio at longer ISIs (150, 200 and 
500 ms) was completely abolished in the presence of CGP 55845 (50 ms APO-UNSUS 0.90 ± 0.03; APO-SUS 
0.89 ± 0.05, p = 0.75; 100 ms APO-UNSUS 0.88 ± 0.02; APO-SUS 0.84 ± 0.02, p = 0.29; 150 ms APO-UNSUS 
0.81 ± 0.01; APO-SUS 0.82 ± 0.04, p = 0.68; 200 ms APO-UNSUS 0.79 ± 0.02; APO-SUS 0.82 ± 0.03, p = 0.38; 
500 ms APO-UNSUS 0.81 ± 0.02; APO-SUS 0.83 ± 0.02, p = 0.24; Fig. 4c,d), indicating that increased GABAB 
receptor signaling underlies the decreased paired-pulse ratio in APO-SUS compared to APO-UNSUS rats. Of 
note, blocking of GABAB receptors with CGP 55845 had no effect on the paired-pulse ratio of APO-UNSUS rats 
at all ISIs tested (Fig. 4e,f), indicating that GABAB receptor signaling does not play a role in these experiments in 
APO-UNSUS rats.
Increased expression of GABAB receptors, but not GAT1, in the mPFC of APO-SUS rats. The 
increase in GABAB receptor signaling could be caused either by an increase of GABAB receptor activation, 
through increased levels of extracellular GABA, or by an increase in the number of GABAB receptors. Increased 
levels of extracellular GABA could be caused by a reduction in the expression of GAT1, the main GABA trans-
porter in the central nervous system41. GAT1 reduces the amount of extracellular GABA in the synapse, which 
reduces spillover41. GABAB receptors are located perisynaptically, and are activated by GABA spillover. In addi-
tion, reduced GAT1 expression has been found in schizophrenia patients42 and animal models12 of schizophrenia. 
We therefore first assessed the levels of GAT1 in punches from the mPFC of APO-SUS and APO-UNSUS 
rats by performing western blot analysis. However, we found no significant difference between APO-SUS and 
APO-UNSUS rats (p = 0.73; Fig. 5a,b). We next studied the protein expression levels of GABAB receptors. 
Western blot analysis using an antibody against the GABAB1 subunit, which together with the GABAB2 receptor 
forms an active GABAB receptor43, revealed that the levels of GABAB1 were increased by ~110% in the mPFC of 
APO-SUS rats compared to APO-UNSUS mPFC (p < 0.05; Fig. 5a,b). Together, our data suggest that increased 
GABAB receptor signaling in APO-SUS rats is accompanied by increased expression of the GABAB1 subunit, and 
underlies the decreased paired-pulse ratio in APO-SUS rats.
Morphology UNSUS SUS p-value Sign
Basal Dendrites
Quantity 6.0 ± 0.9 9.3 ± 1.4 0.029 n.s.
Nodes 18.5 ± 2.1 20.8 ± 2.5 0.404 n.s.
Ends 24.3 ± 2.6 29.8 ± 1.8 0.060 n.s.
Length (μ m) 2339.9 ± 407.5 2659.7 ± 189.1 0.433 n.s.
Mean length 397.2 ± 59.1 312.8 ± 54.4 0.224 n.s.
Apical Dendrite
Nodes 15.0 ± 1.7 22.0 ± 4.0 0.093 n.s.
Ends 16.0 ± 1.7 23.0 ± 4.0 0.093 n.s.
Length (μ m) 1775.9 ± 183.1 2617.7 ± 490.4 0.085 n.s.
Max Branch 
Order 8.0 ± 0.5 11.0 ± 0.8 0.009 n.s.
Convex Hull
Area (μ m2) 43375.2 ± 2899.2 55194.9 ± 8447.3 0.143 n.s.
Perimeter (μ m) 831.0 ± 20.8 929.5 ± 66.6 0.116 n.s.
Table 1.  Dendritic morphological analysis of reconstructed layer II/III pyramidal cells. Student’s t-test with 
Holm-Sidak correction for multiple comparisons. Data is presented as mean ± SEM. Sign: significance; n.s: not 
significant.
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Discussion
The GABAergic system plays an important role in the pathophysiology of schizophrenia44,45. Here, using the 
APO-SUS/APO-UNSUS rat model at PND 20–22 we further highlight the importance of dysfunctional GABA 
signaling in schizophrenia-related traits. We provide several lines of evidence for deficits in the inhibitory 
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Figure 4. APO-SUS rats show a reduced paired-pulse ratio at long ≥ 150 ms inter-stimulus intervals (ISI). 
(a,b) Representative traces (a) and quantification (b) of the paired-pulse ratio at different ISIs from APO-UNSUS 
(n = 14/3) and APO-SUS (n = 15/4) rats. (c,d) Representative traces (c) and quantification (d) of the paired-pulse 
ratio at different ISIs in the presence of the GABAB antagonist CGP 55845 from APO-UNSUS (n = 10/3) and APO-
SUS (n = 12/3) rats. (e,f) Comparison between APO-UNSUS in the absence or presence of CGP 55845, note that 
these traces are the same as in a–d. Representative traces show an overlay of all 5 individual inter-stimulus intervals. 
Sample size (n) is shown as number of cells/number of animals. Data are presented as mean ± SEM. *p < 0.05; 
**p < 0.01. Student’s t-test with Holm-Sidak correction for multiple comparisons.
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Figure 5. The expression of GABAB1, but not GAT1, is increased in the medial prefrontal cortex of APO-
SUS rats. (a) Representative blot and (b) quantification of western blot analysis for GAT1 and GABAB1 on 
APO-UNSUS and APO-SUS. Expression is normalized to APO-UNSUS expression of the respective protein. 
Sample size (n) is indicated in the bars. Data is presented as mean ± SEM, *p < 0.05. Student’s t-test.
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circuitry within the PRL of APO-SUS rats: (i) a reduced level of GAD67 in interneurons in the mPFC of APO-SUS 
rats, specifically in the PRL; (ii) a reduced paired-pulse ratio at longer (≥ 150 ms) ISIs in APO-SUS rats; and (iii) 
increased GABAB signaling due to an increased expression of the GABAB1 subunit of the GABAB receptor. Finally, 
we were able to reverse the increased GABAB signaling in APO-SUS rats by the application of the GABAB antag-
onist CGP 55845.
In our present study on the GABAergic system in the APO-SUS rats, we observed a decreased protein level 
of GAD67 in the PRL. Also, we found a reduced number of GAD67+ cells in this region. However, the number 
of CB+, CR+ and PV+ neurons, which together account for ~90% of interneurons30, remained unchanged in the 
APO-SUS rat, indicating that the total number of interneurons is unaltered. The reduced number of GAD67+ 
cells could result from a reduction of GAD67 levels per cell, causing these interneurons to be under the detection 
threshold of our analysis. Indeed, reduced levels of GAD67 have been reported before in schizophrenia both in 
animal models and post-mortem patient studies17,46,47.
A number of studies has shown that reduced prefrontal inhibitory transmission induces various cognitive, 
emotional and dopaminergic abnormalities that resemble aspects of schizophrenia48. More specifically, reduced 
GABAergic activity in the PRL of the rat PFC results in deficits in speed of processing information, cognitive flex-
ibility, recall of relevant information and enhanced dopamine activity49,50. In this respect, it is of interest to note 
that GABAergic interneurons in the mPFC receive direct input from mesocortical dopaminergic fibers, and this 
control matures during adolescence and appears crucial for cortical network activity at adulthood51. Moreover, 
together with the genetic background and environmental stress the developmental ingrowth of dopaminergic fib-
ers may lead to an abnormal functioning of the GABAergic interneurons at adulthood, especially under stressful 
conditions that also alter the dopamine system52. A functional dysregulation of the mesostriatal dopaminergic 
neurons in schizophrenia has indeed been well established8,53,54.
Given that we found altered levels of GAD67 in the mPFC of APO-SUS rats, indicative of a reduced inhibitory 
drive, we studied changes in the basal synaptic input connectivity of LII/III pyramidal neurons. Surprisingly, 
mIPSC amplitude and frequency on these neurons were unaltered, as was the presynaptic release probability for 
GABA, suggesting that the changes in interneuron composition were not accompanied by changes in basal syn-
aptic input. Additionally, we did not observe any changes in the response to bath application of GABA, indicating 
that the total number of GABAA receptors was unaltered. Together, these results suggest that the total number 
and strength of inhibitory synapses are not different between APO-SUS and APO-UNSUS rats. However, this 
study does not include a measure of excitability of the individual classes of interneurons within the mPFC and 
it is conceivable that the reduced inhibitory activity is due to a reduced excitability of one or more subclasses of 
interneurons. The use of reporter rodent lines will allow the targeted exploration of the excitability of specific 
interneuron subclasses in future studies.
While we did not observe differences at the level of synaptic transmission and morphology of LII/III pyram-
idal cells, we found a clear reduction in the paired-pulse ratio in the APO-SUS compared to APO-UNSUS rats. 
This reduction was specific for ISIs ≥150 ms, and was not observed in ≤ 100 ms ISIs. The reduced paired-pulse 
ratio at ≥ 150 ms ISIs indicates a reduced release of neurotransmitter at the second pulse. We show that enhanced 
GABAB receptor signaling, at least in part, underlies this reduction. Indeed, the paired-pulse ratio in the 
APO-SUS rats could be restored to the levels observed in the APO-UNSUS rats by application of the GABAB 
receptor antagonist CGP 55845. GABAB receptors are metabotropic G-protein-coupled GABA receptors, and are 
located perisynaptically at both the pre- and postsynapse55. Presynaptic GABAB receptors reduce calcium inflow 
mainly by inhibiting N- type and P/Q type voltage-gated calcium channels and to a lesser extent by activating 
inward-rectifying potassium channels such as Kir3, causing a hyperpolarization55. Both pathways reduce the 
inflow of calcium, and occur with a delay of ~150 ms and slow decay of ~1 s40 consistent with the maximal effect 
that we observed at the 150 ms ISI. Postsynaptic GABAB receptors mediate opening of potassium channels, but 
both the absence of an outward current in our recordings as well as the use of a cesium-based intracellular record-
ing solution exclude the possibility of a postsynaptic contribution of GABAB receptors to our recordings and 
point to presynaptic GABAB receptor activity underlying the observed changes. Activation of presynaptic GABAB 
receptors reduces calcium conductance and subsequent GABA release, and therefore provides a negative feedback 
to the GABAergic system56,57. Interestingly, a reduced inhibitory input onto excitatory pyramidal cells has been 
found in models for schizophrenia20 and autism58, and underlines the notion that a proper tuning of excitation 
and inhibition is required for proper brain function11. Importantly, a number of studies have highlighted a crucial 
link between GABA transmission and cognitive dysfunction in schizophrenia, indicating that reduced prefron-
tal inhibitory transmission induces various cognitive, emotional and dopaminergic abnormalities that resemble 
aspects of this disorder48.
Consistent with our finding of increased GABAB signaling, we show that the expression of GABAB1 is 
increased in the mPFC of APO-SUS compared to APO-UNSUS rats. However, our results do not show if the 
increase in GABAB1 is due to an increase in the number of GABAB1-expressing cells, or an increase in the amount 
of GABAB1 per cell. Thus far, no comparative studies are available describing the levels of GABAB receptors in 
individual interneuron subtypes. Interestingly, a reduction in GABAB subunit expression has been observed in 
various brain regions of schizophrenia patients59–61. In humans, stimulation of cortical GABAB receptors in the 
fronto-parietal network has led to better attentional allocation in reinforcement learning62. In addition, GABAB 
receptor manipulation has been shown to reverse behavioral changes related to psychosis63, improve pre-pulse 
inhibition deficits and ameliorate sensorimotor gating in rodent models64. Combining the results of the present 
animal study with the results of the previously reported patient studies suggests that both reduced as well as 
increased GABAB signaling may underlie some of the aspects of schizophrenia. Of note, most schizophrenia 
research on patients is hampered by the use of medication, whereas the rat model used in this study is drug 
naive. Additional preclinical studies are warranted to further evaluate the hypothesis that the GABAB receptor 
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represents a promising pharmacological target for treating appropriately stratified subsets of individuals with 
schizophrenia.
It is important to notice that schizophrenia is a disorder with an onset during adolescence or early adulthood65. 
The PND 20–22 rats used for this study are in their early adolescence, and therefore do not necessarily display 
the schizophrenia-relevant features that have been described in adult rats21–26. Even though the exact mecha-
nisms underlying neurodevelopmental disorders, including schizophrenia, are unknown, many theories exist 
about a distorted balance between neuronal excitation and inhibition during development51,66,67. While it is dif-
ficult to distinguish primary effects from homeostatic- and compensatory mechanisms, a substantial amount 
of evidence points in the direction of disrupted inhibitory signaling as an important factor in the etiology of 
schizophrenia51,68,69. Our data suggest a possible role for GABAB receptor signaling in the development of the 
schizophrenia-relevant features observed in adult APO-SUS rats.
In conclusion, our findings highlight the importance of GABAergic signaling for inducing 
schizophrenia-related phenotypes, and identify GABAB receptors as potential new key players in the distorted 
network functioning in this disorder.
Methods
Animals. All experiments were performed with male Wistar (PND20–22) rats pharmacogenetically selected 
for high susceptibility (APO-SUS) or low susceptibility (APO-UNSUS) to apomorphine. The generation of APO-
SUS and APO-UNSUS rat lines has been described previously21. In short, upon injection of apomorphine, a 
bimodal distribution of the gnawing response was found, i.e. approximately 40% of the Wistar rats showed a 
weak gnawing response (< 10 counts/45 min) and a similar percentage showed an intense gnawing response 
(> 500 counts/45 min). Following this initial selection, the nine males and females with the highest scores, and the 
nine males and females with the lowest scores were paired and their offspring was again tested for their gnawing 
response. For each new generation, nine new pairs of rats were selected out of the four male and female litters 
showing the highest (APO-SUS) and the lowest (APO-UNSUS) mean gnawing response per gender, with the 
condition that brother/sister pairing was not allowed. APO-SUS rats are defined as animals born from an APO-
SUS mother and father; APO-UNSUS rats are likewise defined as animals born from an APO-UNSUS mother 
and father. The present experiments were performed with naive male APO-SUS and APO-UNSUS rats belonging 
to the 38th and 40th generation, i.e. apomorphine was used only during the procedure to select and generate the 
APO-SUS and APO-UNSUS lines.
All rats were bred and reared in the Central Animal Facility of the Radboud University Nijmegen. The animals 
were reared and housed in macrolon cages (42 × 26 × 15 cm) in a controlled (20 ± 2 °C) and enriched environ-
ment under a 12 h light/dark cycle (lights on at 7:00 A.M.). Food pellets and water were provided ad libitum. 
Experimental procedures were performed between 9:00 A.M. and 5:00 P.M. The experimental procedures were 
approved by the Animal Ethics Committee of the Radboud University Nijmegen (Nijmegen, the Netherlands) 
and conducted in accordance with the Dutch legislation. Every effort was made to minimize the number of ani-
mals used and their suffering.
Western blotting. For the western blot experiments the animals were decapitated and the brains were col-
lected quickly, frozen on dry ice, and kept at − 80 °C. The brains were sliced into 200 μ m coronal sections using 
a cryostat (Microm HM 500OM) at − 15 °C and mounted on glass slides. Punches from 6 sections of the mPFC 
(prelimbic and infralimbic region) were taken with a 2 mm diameter micropunch needle (Harris Inc.) between 
the first appearance of the corpus callosum and the start of the caudate putamen. The coordinates were deter-
mined according to the atlas of Paxinos and Watson70. Samples from each hemisphere were pooled. All the sam-
ples were stored at − 80 °C before protein extraction took place.
Brain punches were homogenized in 50 μ l of lysis buffer (50 mM Hepes pH 7.4, 140 mM NaCl, 0.1% 
Triton-X100, 1% Tween 20, 0.1% deoxycholate) supplemented with protease inhibitor mix (Roche Diagnostics). 
The protein levels were assessed using the Bradford assay. After protein measurement, sodium dodecyl sulfate 
polyacrilamide gel electrophoresis (SDS-PAGE) on 10% (w/v) at 100 V for 90 minutes was carried out using 
a Mini-Protean system (Bio-Rad, USA). Protein (40 μ g) was loaded in each lane with loading buffer (0.25 M 
Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, 0.25% bromophenolblue, 4% beta-mercaptoethanol). After electropho-
resis, proteins were transferred to a polyvinylidene fluoride membrane (PVDF, Amersham, Hybond-P), using 
an electrophoretic transfer system (Bio-Rad, USA) at 400 mA for 90 minutes. The membranes were then blocked 
with 5% skimmed milk dissolved in 0.1 M PBS for one hour. The membranes were incubated overnight at 4 °C 
with the primary antibodies diluted in blocking buffer containing 5% skimmed milk dissolved in a PBS Tween 
20 mixture (5%) (PBS-T, Sigma-Aldrich). The primary antibodies were the following: mouse monoclonal anti-
bodies for CB D-28K (1:1000, Swant), CR (1:1000, Swant), GAD67 (1:1000, Abcam), GAT1 (1:500, Abcam), 
GABAB1 (1:500, Abcam), and gamma-tubulin (1:10000, Sigma). After being washed for one hour with 1% 
skimmed milk in PBS-T (0.05%), the membranes were incubated for one hour in the dark at room tempera-
ture with goat-anti-mouse secondary antibody (1:10.000; LI-COR Biosciences Inc; IRDye 680). The membranes 
were imaged using an Odyssey IR-scanner (LI-COR Biosciences, Inc.) and the generated pictures were quanti-
fied using the Odyssey software (Li-COR Biosciences Inc.). The levels of protein expression were normalized to 
beta-tubulin. Protein expression values are normalized to APO-UNSUS values (relative intensity).
Immunohistochemistry. For the fluorescent immunohistochemistry experiments, rats were sacrificed by 
direct decapitation without anesthesia, after which the brains were extracted and post-fixated by immersion in 2% 
paraformaldehyde (PFA) in 0.1 M PBS, pH 7.4 for 48 hours. After post-fixation, the brains were transferred to a 
30% sucrose solution for cryoprotection. Coronal sections (10 μ m) were cut on cryostate, collected on SuperFrost 
glass slides and stored at − 20 °C until further processing.
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Sections (10 μ m) were incubated for 1 h in blocking buffer (5% normal goat, horse and donkey serum, 1% 
BSA, 1% glycine, 0,1% lysine, 0,4% Triton X-100) to minimize nonspecific labeling. Tissue sections were then 
incubated overnight at room temperature with mouse monoclonal primary antibodies diluted in blocking buffer 
against CB D-28k (1:2000; CB300; Swant), CR (1:3500; CR-6B3, Swant), or PV (1:8000; PV-235, Swant); for 
GAD67 (1:5000; K-87, Abcam), incubation was done for 4 h at room temperature, followed by a 65 h incubation 
at 4 °C. The next morning, sections were washed in PBS and placed for 1.5 h in a 1:500 dilution of goat-anti-mouse 
Alexa-fluor 488 secondary antibody (Invitrogen). Hoechst (bisBenzimide dye, No 33342, Sigma B-2261; 1 μ g/mL 
prepared in 0.1 M PBS) staining was performed for nuclear staining. After overnight drying of the sections at 
room temperature, they were coverslipped with FluorSaveTM Reagent (Merck Millipore). The next day, slides 
were visualized with an automated high content epifluorescence microscope with digital image acquisition (Leica 
DMI6000B inverted microscope, Leica EL6000 illumination source). The pictures were manually analyzed and 
quantified at 10X magnification using FIJI3 in a blinded fashion. The values obtained for each animal represent 
the average of measurements taken from 3–4 equally spaced sections for each brain area. Nomenclature of the 
brain was based on the atlas of Paxinos and Watson70.
Electrophysiology. Rats were anesthetized with isoflurane before decapitation. Coronal slices (350 μ m) were 
cut using a HM650V vibration microtome (Thermo Scientific) in ice cold artificial cerebrospinal fluid (ACSF) 
containing (in mM): 124 NaCl; 11 Glucose; 3 KCl; 1.25 NaH2PO4; 1 CaCl2; 4 MgCl2; 26 NaHCO3, continuously 
oxygenated with 95% O2/5% CO2 and incubated for 1 h at room temperature. Slices were transferred to the 
recording setup 15 minutes prior to recording and incubated at 30 °C while being continuously oxygenated with 
95% O2/5% CO2 in recording ACSF containing (unless otherwise stated)(in mM): 124 NaCl, 1.25 NaH2PO4, 
3 KCl, 26 NaHCO3, 10 Glucose, 2 CaCl2, 1 MgCl2. Patch pipettes (3–5 MΩ) were made from borosilicate 
glass capillaries and filled with intracellular solution containing (in mM): 115 CsMeSO3; 20 CsCl; 10 HEPES; 
2.5 MgCl2; 4 Na2ATP; 0.4 NaGTP; 10 Na-Phosphocreatine; 0.6 EGTA. Traces were recorded using a Multiclamp 
700B amplifier (Molecular Devices), sampled at 10 kHz and filtered at 2 kHz. Cells were excluded from analysis 
if the series resistance exceeded 25 MΩ. mIPSCs were recorded in the presence of Tetrodotoxin (TTX, 1 μM), 
6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 5 μM) and (2R)-amino-5-phosphonovaleric acid (APV, 100 μM) 
at a holding potential of +10 mV. mEPSC were recorded in the presence of TTX and Picrotoxin (PTX, 100 μM) 
at a holding potential of −60 mV. Paired-pulse ratio (PPR) was recorded following stimulation in LII/III of the 
PFC in the presence of CNQX and D-APV, in ACSF containing 4 mM CaCl2 and 4 mM MgCl2 to increase the 
stimulated responses, at a holding potential of − 60 mV. Stimulation strength was set to evoke a ~200 pA response 
to the first stimulus. Two 1 ms pulses were given with a 50 ms, 100 ms, 150 ms, 200 ms or 500 ms interval. PPR was 
calculated as peak2/peak1 after correcting for any residual current at the second pulse. CGP 55845 was used at a 
concentration of 10 μ M71. For GABA application, cells were allowed to stabilize their holding current, after which 
20 μ M GABA was washed in. We quantified the maximal change in holding current as the maximal response to 
the washed in GABA. Miniature recordings were analyzed using Mini Analysis Program (Synaptosoft). Other 
traces were analyzed using Clampfit 10.2. All drugs were purchased from Tocris.
Morphological reconstructions. For morphological reconstructions, the internal solution was supple-
mented with 0.4% biocytin (Sigma-Aldrich). Following single-cell electrophysiology, the slices with biocytin-filled 
neurons were fixated in 4% paraformaldehyde in 0.1 M PBS overnight at 4 °C, and subsequently processed follow-
ing a modified staining protocol based on Marx et al.72. In brief: after fixation, slices were rinsed in 0.1 M PB, incu-
bated in 3% H2O2 in 0.1 M PB for 30 minutes at room temperature to quench endogenous peroxidases, rinsed 
in 0.1 M PBS, then incubated in Avidin-Biotin-Peroxidase solution (Vectastain Elite, with 1% v/v Triton-100) 
overnight on a shaking platform at 4 °C. The next day, slices were washed with 0.1 M PBS and pre-incubated with 
Di-Aminobenzidine (DAB) solution with Nickel enhancer (Vector Peroxidase substrate kit, SK-4100) for 30 min. 
Then, the DAB solution was replaced with the same solution plus H2O2 and incubated for ca. 30 seconds. Slices 
were then rinsed in 0.1 M PB, mounted on gelatinized coverslips, and dried for 3–6 h in a custom-made moist 
chamber at room temperature. Slices were dehydrated in an ethanol series and Xylene, put on coverslips and 
sealed with Eukitt (Sigma). Slices were imaged on a Zeiss Axioskop 1 upright brightfield microscope with 20x and 
40x objectives (Zeiss EC Plan-Neofluar, NA 0.5 and 0.75, respectively) and motorized stage (MicroBrightField). 
The camera and motorized stage were connected to a Neurolucida workstation (MicroBrightField). Cells were 
selected based on position in the cortical layer II/III of the prefrontal cortex, pyramidal morphology, and staining 
intensity. Somata, apical and basal dendrites were reconstructed in Neurolucida as three-dimensional drawings. 
Reconstructions were analysed in NeuroExplorer (MicroBrightField) for intrinsic parameters and Sholl analysis.
Statistical analysis. Statistical analysis was performed using Prism (Graphpad). Significance was tested with 
a two-sided Student’s t-test. Correction for multiple comparisons was performed using the Holm-Sidak method 
where indicated. Data is expressed as mean ± SEM. Significance was defined as p < 0.05 (*) or p < 0.01 (**).
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